Buzzetti; Franco

Patent Applications and Registrations

Patent applications and USPTO patent grants for Buzzetti; Franco.The latest application filed is for "method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds".

Company Profile

0.17.3

Buzzetti; Franco - Monza IT
Buzzetti; Franco - Milan IT
Buzzetti; Franco - Monza Milan

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Benzoquinolizinium salt derivatives as anticancer agents Grant 8,188,109 - Lombardi , et al. May 29, 2	2012-05-29
Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds App 20110130581 - Lombardi; Paolo ; et al.	2011-06-02
Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds Grant 7,901,904 - Lombardi , et al. March 8, 2	2011-03-08
Benzoquinolizinium salt derivatives as anticancer agents App 20110015222 - Lombardi; Paolo ; et al.	2011-01-20
Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds App 20100099141 - Lombardi; Paolo ; et al.	2010-04-22
Aryl and heteroaryl purine compounds Grant 5,965,563 - Buzzetti , et al. October 12, 1	1999-10-12
Substituted quinolymethylen-oxindole analogues as tyrosine kinase inhibitors Grant 5,905,149 - Battistini , et al. May 18, 1	1999-05-18
Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation Grant 5,719,135 - Buzzetti , et al. February 17, 1	1998-02-17
Substituted azaindolylidene compounds and process for their preparation Grant 5,663,346 - Buzzetti , et al. September 2, 1	1997-09-02
Arylethenylene compounds which are useful as tyrosine kinase inhibitors Grant 5,627,207 - Buzzetti , et al. May 6, 1	1997-05-06
Arylidene-heterocyclic derivatives and process for their preparation Grant 5,587,385 - Buzzetti , et al. December 24, 1	1996-12-24
Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents Grant 5,576,330 - Buzzetti , et al. November 19, 1	1996-11-19
2-oxindole compounds which have useful tyrosine kinase activity Grant 5,488,057 - Buzzetti , et al. January 30, 1	1996-01-30
Methylen-oxindole derivatives compositions and tyrosine kinase inhibition therewith Grant 5,409,949 - Buzzetti , et al. April 25, 1	1995-04-25
Vinylene-azaindole derivatives Grant 5,397,787 - Buzzetti , et al. March 14, 1	1995-03-14
2-oxindole compounds which are useful as tyrosine kinase inhibitors Grant 5,374,652 - Buzzetti , et al. December 20, 1	1994-12-20
Total synthesis of erbstatin analogs Grant 5,130,472 - Buzzetti , et al. July 14, 1	1992-07-14
Arylvinylamide derivatives and pharmaceutical use Grant 5,122,537 - Buzzetti , et al. June 16, 1	1992-06-16
6- or 7-methylenandrosta-1,4-diene-3,17-dione derivatives and process for their preparation Grant 4,824,830 - Buzzetti , et al. April 25, 1	1989-04-25
4-substituted 6-alkylidenandrosteine-3,17-dione derivatives and process for their preparation Grant 4,822,528 - Colombo , et al. April 18, 1	1989-04-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.